SCHEMBL1334643

SCHEMBL1334643

Cc1cc(COC(=O)NC(C)(C)C)cc(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
CYP3A4 P08684 1/20 0.37
KMT2A Q03164 5/20 0.37
MEN1 O00255 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 2/20 0.36
NR2F2 P24468 1/20 0.36
MAPT P10636 1/20 0.36
SCN9A Q15858 1/20 0.36
RAB9A P51151 2/20 0.35
THRB P10828 1/20 0.35
NAMPT P43490 1/20 0.35
ELANE P08246 1/20 0.35
TOP2A P11388 1/20 0.35
TOP2B Q02880 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1336116 0.98 KDM4E (0.40) KDM4ECYP3A4KMT2AMEN1SMN1; SMN2
SCHEMBL1310486 0.86 MAPT (0.46) KDM4ECYP3A4KMT2AMEN1SMN1; SMN2
SCHEMBL1311745 0.85 MEN1 (0.42) KDM4ECYP3A4KMT2AMEN1SMN1; SMN2
SCHEMBL12126865 0.82 MEN1 (0.42) KDM4ECYP3A4KMT2AMEN1SMN1; SMN2
SCHEMBL28301487 0.79 MEN1 (0.47) KDM4EKMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL12112847 0.78 ITGB3 (0.45) KDM4ECYP3A4KMT2AMEN1SMN1; SMN2
SCHEMBL28861927 0.77 NPC1 (0.51) KMT2AMEN1SMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL1578756 0.77 KDM4E (0.39) KDM4ECYP3A4KMT2AMEN1L3MBTL1
Hydrochloric Acid SCHEMBL1578110 0.76 KDM4E (0.39) KDM4ECYP3A4KMT2AMEN1L3MBTL1
SCHEMBL1578305 0.76 AAK1 (0.36) KDM4ECYP3A4SMN1; SMN2L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275678-A1 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics BIOVITRUM AB (SE) 2011-11-10 US claimed
EP-2313094-A1 NEW PYRIDINE DERIVATIVES AS LEPTIN RECEPTOR MODULATOR MIMETICS AstraZeneca AB (SE) 2011-04-27 EP claimed
WO-2009147216-A1 NEW PYRIDINE DERIVATIVES AS LEPTIN RECEPTOR MODULATOR MIMETICS BIOVITRUM AB (PUBL) (SE) 2009-12-10 WO claimed
US-20110275678-A1 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics BIOVITRUM AB (SE) 2011-11-10 US disclosed
US-20110275678-A1 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics BIOVITRUM AB (SE) 2011-11-10 US disclosed
US-20110275678-A1 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics BIOVITRUM AB (SE) 2011-11-10 US disclosed
EP-2313094-A1 NEW PYRIDINE DERIVATIVES AS LEPTIN RECEPTOR MODULATOR MIMETICS AstraZeneca AB (SE) 2011-04-27 EP disclosed
WO-2009147216-A1 NEW PYRIDINE DERIVATIVES AS LEPTIN RECEPTOR MODULATOR MIMETICS BIOVITRUM AB (PUBL) (SE) 2009-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275678-A1 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics GPR119, GLP1R, ADIPOR1 KDM4E 1032/4885CYP3A4 2143/4885KMT2A 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.